Bacterial Vaginosis Prevention and Treatment Guidelines

Diagnosis and Risk Factors

Women who have never been sexually active rarely develop Bacterial Vaginosis (BV), and the condition is strongly associated with multiple sex partners and frequency of intercourse 1
While BV is not classified as a classic sexually transmitted infection, sexual transmission dynamics remain unclear, and treating male partners may be beneficial for women with recurrent BV 1

For recurrent cases, consider treating male partners with metronidazole 400 mg orally twice daily for 7 days plus 2% clindamycin cream applied to penile skin twice daily for 7 days 1
Patients must avoid all alcohol during metronidazole treatment and for 24 hours after completion to prevent disulfiram-like reactions 1, 2
Both partners should refrain from unprotected intercourse for at least 14 days to allow treatment to take effect 1

Metronidazole 500 mg orally twice daily for 7 days is the standard first-line treatment with 95% cure rate 3
Alternative regimens include metronidazole gel 0.75% intravaginally once daily for 5 days or clindamycin cream 2% intravaginally at bedtime for 7 days 3
Clindamycin cream is oil-based and might weaken latex condoms and diaphragms, requiring alternative contraception during treatment 3

Women should return if symptoms persist or recur after treatment 2
For pregnant women with BV, follow-up evaluation one month after treatment completion is recommended to verify cure 2
High-risk pregnant women with history of preterm delivery may benefit from treatment as it may reduce risk of prematurity 3
BV during pregnancy is associated with adverse pregnancy outcomes including preterm birth 4
Treatment before surgical abortion procedures substantially reduces post-abortion pelvic inflammatory disease 3
Treatment should be considered before hysterectomy or other invasive gynecological procedures due to increased risk for postoperative infectious complications 3